Highlights
A collection of news and information related to Humira (drug) published by this site and its partners.
Displaying items 1-9 of 9
» View baltimoresun.com items only
-
MedImmune creating drug pipeline for AstraZeneca
When Gail Folena-Wasserman joined Gaithersburg biotechnology startup MedImmune in 1991, she was its first employee in research and development, and dreamed of what the company might be "when it grew up."
Two decades later, the senior vice president for...Tags: Preventative Medicine, AstraZeneca Plc, Respiratory Disease, Lupus, Biotechnology Industry
-
Abbvie says Chief Scientific Officer John Leonard to retire
ReutersMay 10 (Reuters) - AbbVie Inc's chief scientific officer will be retiring in the next few months and will be involved in the process of naming a successor, the pharmaceutical company said in a regulatory filing on Friday. Chief Scientific Officer John M....Tags: Science, Pharmaceuticals, Rheumatoid Arthritis, Hepatitis C , Chemical Industry
-
CORRECTED-Court stops EU regulator releasing drug company data
Reuters(Corrects to make clear competitor sought information on Intermune drug, paragraph 8) By Ben Hirschler LONDON, April 30 (Reuters) - Europe's medicines regulator has been stopped from releasing clinical trial data about drugs made by AbbVie and...Tags: Rheumatoid Arthritis, European Union, Litigation, Drugs and Medicines, Trials
-
Court stops EU regulator releasing drug company data
ReutersBy Ben Hirschler LONDON, April 30 (Reuters) - Europe's medicines regulator has been stopped from releasing clinical trial data about drugs made by AbbVie and Intermune, following a court ruling favouring the two U.S. companies. The European Medicines...Tags: Rheumatoid Arthritis, European Union, Litigation, Drugs and Medicines, Trials
-
Humira sales propel AbbVie in 1Q
Tribune staff reporterIn its first quarter as an independent, publicly traded company, AbbVie Inc. said net income rose 9.6 percent, to $968 million, or 60 cents a share, from $883 million, or 56 cents a share, a year earlier when the company was still a part of Abbott...Tags: Earnings, Companies and Corporations, Rheumatoid Arthritis, Diseases and Illnesses, Hepatitis C
-
BRIEF-AbbVie says expects Q2 EPS, excluding items, of $0.78 to $0.80
ReutersApril 26 (Reuters) - AbbVie Inc : * Says expects Q2 EPS, excluding items, of $0.78 to $0.80 * Says expects Q2 revenue will grow in low single digit percentage range * CEO says EU rejection of pfizer's xeljanz will not have dramatic short-term impact on...Tags: Earnings
-
AbbVie meets expectations, fueled by Humira sales
ReutersApril 26 (Reuters) - AbbVie Inc reported slightly better than expected quarterly results, fueled by surging sales of its Humira treatment for rheumatoid arthritis. The pharmaceuticals business, spun off by Abbott Laboratories at the beginning of the...Tags: Rheumatoid Arthritis, Thomson Corporation, Drugs and Medicines
-
Obese women at increased risk of developing rheumatoid arthritis
Obese women may have an increased risk of developing rheumatoid arthritis — adding one more chronic illness to the list of ills brought on by extra pounds. Women with rheumatoid arthritis are already more prone to heart attacks than the general...
Tags: Heart Attack, Diseases and Illnesses, High Blood Pressure, Cancer, Overweight
-
Lakeview Teen Knows Arthritis is Not Just For Old People
FOX 17 ReporterEighteen year-old Lakeview High School Senior Alex King realized around her freshman year that she was a pretty darn good athlete. Three years later, she is a track all-star and has her sights set on grabbing a state title. For everyone who knew her...Tags: Rheumatoid Arthritis, Arthritis, Knees, Drugs and Medicines
Nov 18, 2012
|Story| Baltimore Sun
May 10, 2013
|Story| Reuters
Apr 30, 2013
|Story| Reuters
Apr 30, 2013
|Story| Reuters
Apr 26, 2013
|Story| Chicago Tribune
Apr 26, 2013
|Story| Reuters
Apr 26, 2013
|Story| Reuters
May 30, 2012
|Story| Chicago Tribune
May 2, 2012
|Story| WXMI
Original site for Humira (drug) topic gallery.
